Comparison Between the Assessment of Anxious and Depressive Symptomology

NCT ID: NCT04148924

Last Updated: 2021-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-15

Study Completion Date

2020-11-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In palliative care, anxiety and depression in advanced cancer are under evaluated, under diagnosed and therefore under treated. 5 to 30% of patients present anxious and depressive disorders.

Physical symptoms are easy to assess. But in palliative care it is important to take care of moral suffering.

However, evaluation and management of patient's anxiety and depressive symptoms are difficult for physicians and caregivers.

The investigators would like to specifically compare the patient's evaluation of anxious and depressive symptomatology in palliative care with the evaluation by the physician, the nurse and the caregiver.

Then the investigators will try to collect the caregivers's difficulties in the management of anxious and depressive symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

Anyone who is hospitalized in the palliative care service of the Lyon Sud Hospital Center.

Questionnaire

Intervention Type OTHER

Patients complete a questionnaire for assess their symptoms like anxiety and depression.

These questionnaires contains:

* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
* HADS - A : Hospital Anxiety and Depression scale includes 2 subscales which assess anxiety (HADS-A) and depression (HADS-D)
* BEDS : Brief Edimburg depression Scale is s a relevant scale for assess depression in palliative care patients.
* Questions on the assessment, the treatment and difficulties in management of anxious and depressive symptoms.

The evaluation will be realized in the first days of hospitalization (72 hours).

Doctors

Doctors taking care of patients in the study will be solicited by the research nurse or a study investigator.

Medical staff questionnaire

Intervention Type OTHER

Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours).

Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit.

These questionnaires contains:

* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms

Nurses

Nurses taking care of patients in the study will be solicited by the research nurse or a study investigator.

Medical staff questionnaire

Intervention Type OTHER

Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours).

Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit.

These questionnaires contains:

* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms

Caregivers

Caregivers taking care of patients in the study will be solicited by the research nurse or a study investigator.

Medical staff questionnaire

Intervention Type OTHER

Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours).

Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit.

These questionnaires contains:

* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Patients complete a questionnaire for assess their symptoms like anxiety and depression.

These questionnaires contains:

* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
* HADS - A : Hospital Anxiety and Depression scale includes 2 subscales which assess anxiety (HADS-A) and depression (HADS-D)
* BEDS : Brief Edimburg depression Scale is s a relevant scale for assess depression in palliative care patients.
* Questions on the assessment, the treatment and difficulties in management of anxious and depressive symptoms.

The evaluation will be realized in the first days of hospitalization (72 hours).

Intervention Type OTHER

Medical staff questionnaire

Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours).

Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit.

These questionnaires contains:

* socio-demographic characteristics : sex, age, type and stage of cancer, performans status
* ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients :

* Adult patients (18 years and over)
* Advanced cancer stage
* Patients hospitalized less than 72 hours in Lyon Sud palliative care unit
* Sufficient general conditions to complete survey
* Absence of cognitive disorders
* Agreement to participate at the study

Medical Staff:

\- Working full time or part time in the USP or the PMSC of CHLS

Exclusion Criteria

Patients :

* Minor patients
* Patients hospitalized more than 72 hours in Lyon Sud palliative care unit
* Presence of cognitive disorders
* Alteration of general conditions
* Refusal to participate at the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Audrey FAWOUBO, MD

Role: PRINCIPAL_INVESTIGATOR

Hospices Civils de Lyon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Lyon Sud

Pierre-Bénite, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL19_0301

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.